Mometason Ratiopharm (Mometasone Furoate)

Mometasone furoate, the active ingredient in Mometason Ratiopharm, is a corticosteroid presented as a nasal spray for endosinusial, nasal use. It reduces inflammation in the nasal passages and is indicated for allergic rhinitis, seasonal allergic rhinitis and nasal polyps.

GNH USA supplies Mometason Ratiopharm as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable sourcing for global healthcare providers. Its distribution network ensures timely delivery and compliance with local regulatory requirements.

Mometason Ratiopharm, a topical corticosteroid, is employed to manage inflammatory conditions of the nasal mucosa.

Allergic rhinitis: relief of nasal congestion, itching and sneezing. Seasonal allergic rhinitis: control of symptoms triggered by seasonal allergens such as pollen. Nasal polyps: reduction of polyp size and improvement of nasal airflow.

Mometason Ratiopharm may cause local and systemic adverse reactions, most of which are mild and reversible.

Common Side Effects: - Nasal irritation or burning sensation. - Dryness of the nasal mucosa. - Epistaxis (nosebleeds). - Headache. - Altered taste perception. - Throat irritation.

Serious or Rare Side Effects: - Severe or persistent nosebleeds. - Vision changes or cataract formation. - Adrenal suppression with systemic exposure. - Allergic reactions such as rash or angioedema. - Fungal infection of the nasal passages. - Perforation of the nasal septum.

Before prescribing Mometason Ratiopharm, clinicians should consider the following precautions.

Assess patient history: confirm diagnosis of allergic rhinitis or nasal polyps before use. Avoid use in patients with known hypersensitivity to mometasone or other corticosteroids. Do not use concomitantly with nasal decongestant sprays for prolonged periods. Monitor for signs of local infection or ulceration in the nasal mucosa. Limit duration of continuous use as advised by the prescriber. Store below 25°C: keep in the original pack, protect from moisture.

Mometason Ratiopharm can interact with other medicines; notable interactions include.

Major Interactions (Avoid): - Concurrent systemic corticosteroids: increased systemic exposure. - Strong CYP3A4 inhibitors (e.g., ketoconazole): may raise local concentration. - Nasal vaccines: may reduce vaccine efficacy.

Moderate Interactions (Monitor Closely): - Antihistamine nasal sprays: may increase dryness. - Other intranasal medications: assess for additive irritation.